Request for Covid-19 Impact Assessment of this Report

Take Action
Medical Devices

Global Hemophilia Market Size study, by Disease Type (Hemophilia A, Hemophilia B, Others), by Therapy (Replacement Therapy, Gene Therapy, Others), by Product Type (Recombinant Coagulation Factor Concentrates, Plasma-derived Coagulation Factor Concentrates, and Others), and Regional Forecasts 2021-2027

  • BIZ4599807
  • 200 Pages
  • July 2021
  • Medical Devices
Download Sample    Get Discount   
 
Global hemophilia market is expected to reach $18 billion by 2027. Global hemophilia market is valued approximately at $12.4 billion in 2020 and is anticipated to grow with a healthy growth rate of about 5.5% over the forecast period 2021-2027. Hemophilia is a bleeding disorder in which blood clotting does not occur properly and leads to spontaneous bleeding followed by injuries and surgeries. The global hemophilia marketis being driven by growing prevalence of bleeding disorders and favorable government initiatives. Furthermore, there have been research and development activities coupled with new product developmentin recent years related to hemophilia treatment whichwill provide new opportunities for the global hemophilia industry. For instance, according to the American Association for the Advancement of Science, in 2020, researchers from the Wake Forest Institute for Regenerative Medicine (WFIRM) announced the development of an optimized cellular platform to deliver Factor 8 to offer better treatment to patients with hemophilia A. Also, in 2018, RCSI (University of Medicine and Health Sciences) and Bayer AG entered into a research collaboration aimed atenhancingtreatments for people experiencing severe hemophilia. The collaboration also aimed to explore new treatment methods that can effectively and safely promote blood clotting in people experiencing hemophilia. Such research and development activities related to hemophilia is expected to drive the market growth during the forecast period. However,high cost of treatmentmay impede market growth over the forecast period of 2021-2027.

The regional analysis of the global hemophilia market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to increasing therapeutic advancements in hemophilia,increasing prevalence of hemophilia,advancements in gene therapy,etc. in the region. Whereas Asia Pacificis anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to earlydisease diagnosis in countries,etc. across the region.

Major market player included in this report are:

Bayer AG

BioMarin Pharmaceutical, Inc.

CSL Behring

Kedrion S.p.A

Novo Nordisk

Pfizer, Inc.

Roche (Chugai Pharmaceutical Co.)

Sanofi (Genzyme Corporation)

Takeda Pharmaceutical (Shire Plc.)

Genentech

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

Hemophilia A

Hemophilia B

Others

By Therapy:

Replacement Therapy

Gene Therapy

Others

By Product Type:

Recombinant Coagulation Factor Concentrates

Plasma-derived Coagulation Factor Concentrates

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027.

Target Audience of the Global Hemophilia Marketin Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Hemophilia Market, by Region, 2019-2027 (USD Billion)

1.2.2. Hemophilia Market, by Disease Type, 2019-2027 (USD Billion)

1.2.3. Hemophilia Market, by Therapy, 2019-2027 (USD Billion)

1.2.4. Hemophilia Market, by Product Type, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Hemophilia Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Hemophilia Market Dynamics

3.1. Hemophilia Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Growing prevalence of bleeding disorders

3.1.1.2. Favourable government initiatives

3.1.2. Market Restraint

3.1.2.1. High cost of treatment

3.1.3. Market Opportunities

3.1.3.1. Rising R&D and new product development

Chapter 4. Global Hemophilia Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Hemophilia Market, by Disease Type

a. Market Snapshot

5.1. Global Hemophilia Market by Disease Type, Performance - Potential Analysis

5.2. Global Hemophilia Market Estimates & Forecasts by Disease Type 2018-2027 (USD Billion)

5.3. Hemophilia Market, Sub Segment Analysis

5.3.1. Hemophilia A

5.3.2. Hemophilia B

5.3.3. Others

Chapter 6. Global Hemophilia Market, by Therapy

6.1. Market Snapshot

6.2. Global Hemophilia Market by Therapy, Performance - Potential Analysis

6.3. Global Hemophilia Market Estimates & Forecasts by Therapy 2018-2027 (USD Billion)

6.4. Hemophilia Market, Sub Segment Analysis

6.4.1. Replacement Therapy

6.4.2. Gene Therapy

6.4.3. Others

Chapter 7. Global Hemophilia Market, by Product Type

7.1. Market Snapshot

7.2. Global Hemophilia Market by Product Type, Performance - Potential Analysis

7.3. Global Hemophilia Market Estimates & Forecasts by Product Type 2018-2027 (USD Billion)

7.4. Hemophilia Market, Sub Segment Analysis

7.4.1. Recombinant Coagulation Factor Concentrates

7.4.2. Plasma-derived Coagulation Factor Concentrates

7.4.3. Others

Chapter 8. Global Hemophilia Market, Regional Analysis

8.1. Hemophilia Market, Regional Market Snapshot

8.2. North America Hemophilia Market

8.2.1. U.S. Hemophilia Market

8.2.1.1. Disease Type breakdown estimates & forecasts, 2018-2027

8.2.1.2. Therapy breakdown estimates & forecasts, 2018-2027

8.2.1.3. Product Type breakdown estimates & forecasts, 2018-2027

8.2.2. Canada Hemophilia Market

8.3. Europe Hemophilia Market Snapshot

8.3.1. U.K. Hemophilia Market

8.3.2. Germany Hemophilia Market

8.3.3. France Hemophilia Market

8.3.4. Spain Hemophilia Market

8.3.5. Italy Hemophilia Market

8.3.6. Rest of Europe Hemophilia Market

8.4. Asia-Pacific Hemophilia Market Snapshot

8.4.1. China Hemophilia Market

8.4.2. India Hemophilia Market

8.4.3. Japan Hemophilia Market

8.4.4. Australia Hemophilia Market

8.4.5. South Korea Hemophilia Market

8.4.6. Rest of Asia Pacific Hemophilia Market

8.5. Latin America Hemophilia Market Snapshot

8.5.1. Brazil Hemophilia Market

8.5.2. Mexico Hemophilia Market

8.6. Rest of The World Hemophilia Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Bayer AG

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. BioMarin Pharmaceutical, Inc.

9.2.3. CSL Behring

9.2.4. Kedrion S.p.A

9.2.5. Novo Nordisk

9.2.6. Pfizer, Inc.

9.2.7. Roche (Chugai Pharmaceutical Co.)

9.2.8. Sanofi (Genzyme Corporation)

9.2.9. Takeda Pharmaceutical (Shire Plc.)

9.2.10. Genentech

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

TABLE 2. Global Hemophilia Market, report scope

TABLE 3. Global Hemophilia Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 4. Global Hemophilia Market estimates & forecasts by Disease Type2018-2027 (USD Billion)

TABLE 5. Global Hemophilia Market estimates & forecasts by Therapy 2018-2027 (USD Billion)

TABLE 6. Global Hemophilia Market estimates & forecasts by Product Type 2018-2027 (USD Billion)

TABLE 7. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. U.S. Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 24. U.S. Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. U.S. Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Canada Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 27. Canada Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. Canada Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. UK Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 30. UK Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. UK Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. Germany Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 33. Germany Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. Germany Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. France Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 36. France Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. France Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Spain Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 39. Spain Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. Spain Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Italy Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 42. Italy Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. Italy Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. ROE Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 45. ROE Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. ROE Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. China Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 48. China Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. China Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. India Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 51. India Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. India Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Japan Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 54. Japan Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. Japan Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. Australia Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 57. Australia Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 58. Australia Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 59. South Korea Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 60. South Korea Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 61. South Korea Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 62. ROPAC Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 63. ROPAC Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 64. ROPAC Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 65. Brazil Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 66. Brazil Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 67. Brazil Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 68. Mexico Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 69. Mexico Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 70. Mexico Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 71. ROLA Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 72. ROLA Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 73. ROLA Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 74. ROW Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 75. ROW Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 76. ROW Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 77. List of secondary sources used in the study of global Hemophilia Market.

TABLE 78. List of primary sources used in the study of global Hemophilia Market.

TABLE 79. Years considered for the study.

TABLE 80. Exchange rates considered.

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
View Details
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
View Details
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research